Insurance assistance to help patients explore coverage options
If you have a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with a weight-related medical condition such as high blood pressure or type 2 diabetes, you may be a good candidate for Semaglutide weight loss
What kind of program GLP-1 is Medically supervised weight management using GLP-1 medications, compounded semaglutide (GLP-1 receptor agonist, from $215/month) and compounded tirzepatide (dual GIP/GLP-1 receptor agonist, from $375/month), each requiring a consultation, lab work, and provider oversight
This triple mechanism, explained thoroughly in the GLP-3 (triple agonist) peptide guide , explains why retatrutide produced weight reduction of up to 24.2% at 48 weeks in phase 2 trials, numbers that exceeded both semaglutide and tirzepatide weight loss outcomes at similar timepoints
Patients should be very cautious
"Triple-hormone-receptor agonist retatrutide for obesitya phase 2 trial." New England Journal of Medicine
